11:56 AM EDT, 06/03/2025 (MT Newswires) -- Pavmed ( PAVM ) said Tuesday that its digital health unit Veris Health signed a long-term strategic partnership agreement with The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, also known as OSUCCC - James.

Pavmed ( PAVM ) said the partnership aims to use and advance the development and commercialization of the Veris Cancer Care Platform and its implantable physiologic monitor. This covers expanding the platform's use across cancer care service lines and full electronic health record integration, among others.

The partnership deal follows the completion of a pilot program of the Veris Cancer Care Platform at OSUCCC - James, Pavmed ( PAVM ) said.

Shares were up 0.8% in recent trading.

Price: 0.62, Change: +0.01, Percent Change: +0.82